APA (7th ed.) Citation

MR, G., A, C., CJ, S., M, B., PJ, S., MA, G., . . . BMK, B. (2024). Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. The Journal of clinical endocrinology and metabolism, 110(1), 228. https://doi.org/10.1210/clinem/dgae385

Chicago Style (17th ed.) Citation

MR, Gadelha, et al. "Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine." The Journal of Clinical Endocrinology and Metabolism 110, no. 1 (2024): 228. https://doi.org/10.1210/clinem/dgae385.

MLA (9th ed.) Citation

MR, Gadelha, et al. "Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine." The Journal of Clinical Endocrinology and Metabolism, vol. 110, no. 1, 2024, p. 228, https://doi.org/10.1210/clinem/dgae385.